Because AD is a type I IgE-mediated hypersensitivity reaction contributing to immune dysregulation and its major characteristics is hyperproduction of IgE, we examined the plasma IgE levels in the mice treated with KIOM-MA or KIOM-MA128 and compared with that of control. This evidence concerns the gene IGHE and Alzheimer disease.